tiprankstipranks
Advertisement
Advertisement

Fidia Issues 1 Million New Shares After Bond Conversion

Story Highlights
  • Fidia converted 10 POC bonds into 1,000,000 new shares at €0.10 each.
  • The bond conversion lifts Fidia’s share capital to €9.95 million with 31.3 million shares outstanding.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Fidia Issues 1 Million New Shares After Bond Conversion

Claim 30% Off TipRanks

An update from Fidia Spa ( (IT:FDA) ) is now available.

Fidia S.p.A. has converted 10 bonds from the first tranche of its convertible bond loan with warrants reserved for Global Growth Holding Limited into 1,000,000 new shares at a price of €0.10 per share, which are being admitted directly to trading on the regulated market. Following this transaction, the company’s share capital increases by €100,000 to €9,947,761.90, bringing the total number of shares to 31,298,485, while 15 subscribed bonds remain outstanding and unconverted under the POC.

The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.

More about Fidia Spa

Fidia S.p.A., based in Turin and listed on Euronext Milan, is a leading global provider of numerical control technology and high-performance integrated milling systems. With more than 40 years of experience and around 135 employees, it serves primarily the mould segment for the automotive and aerospace industries, offering complete solutions from machining program definition to finished product, including controls, milling machines and CAM software.

Average Trading Volume: 977,090

Technical Sentiment Signal: Strong Sell

Current Market Cap: €3.48M

For a thorough assessment of FDA stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1